A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

Clinical trial NCT05370755 · UNKNOWN

Trial details

NCT number: NCT05370755
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Patients With Advanced Solid Tumors

Start date: 2022-05-31
Primary completion: 2024-05-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.